Prolonged QRS duration (QRS ≥170 ms) and left axis deviation in the presence of left bundle branch block: A marker of poor left ventricular systolic function?

详细信息    查看全文

• 作者：Mithilesh Kumar Das ; Kuruvilla Cheriparambil ; Ashwini Bedi ; John Kassotis ; Eng Sci D ; Chatla V. R. Reddy ; Majesh Makan ; Christopher C. Dunbar ; Barry Saul
• 刊名：American Heart Journal
• 出版年：2001
• 出版时间：November 2001
• 年：2001
• 卷：142
• 期：5
• 页码：756-759
• 全文大小：83 K

文摘

Background Left bundle branch block (LBBB) is commonly associated with structural heart disease and left ventricular dysfunction. We propose that the QRS duration and degree of left-axis deviation (LAD) identify significant left ventricular systolic dysfunction in patients with LBBB. Methods In this prospective study the ejection fraction (EF) of 300 consecutive patients with LBBB was evaluated by echocardiography. The relationship between QRS duration and LAD (axis between –30° and –90°) and EF were derived. Results There was no significant difference in age, sex, presence of ischemic or nonischemic cardiomyopathy and valvular heart disease, and EF among the patients with or without LAD. The EF of patients with QRS ≥170 milliseconds with LAD (n = 20) and without LAD (n = 18) was 25 % ± 16 % and 23 % ± 13 % , respectively (P = .71). The mean EF (24 % ± 10 % ) of the patients with a QRS duration of ≥170 milliseconds (n = 38) was significantly lower than the mean EF (36 % ± 16 % ) of the patients with a QRS duration of <170 milliseconds (n = 262, P < .015). The QRS duration also had a significant (P < .001) inverse correlation with EF (R = 0.37, adjusted R² = 0.13, SE of ESTIMATE = 16.21). However, the QRS axis was not significantly correlated with EF and did not have added predictive value. Conclusions The QRS duration has a significant inverse relationship with EF and prolongation of QRS duration (≥170 milliseconds) in the presence of LBBB is a marker of significant left ventricular systolic dysfunction. The presence of LAD in LBBB does not signify a further decrease in EF. (Am Heart J 2001;142:756-9.)